BioDisrupt, Amyris Annual Investor Conference Provides Close-up of Technology & Strategy
EMERYVILLE, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Leading biotech firm Amyris, Inc. (Nasdaq:AMRS), will host its annual investor conference, BioDisrupt, on May 22, 2018 at the company’s Emeryville headquarters. BioDisrupt gives industry participants and investors an opportunity to gain an up-close view of the company’s pioneering design and development platform for commercializing No Compromise™ molecules, as well as the strategy behind its very successful evolution to focus on high-margin Health and Beauty consumer products & ingredients. The company plans to videocast a portion of the event, including formal presentations and panel discussions, starting at approximately 11:30 a.m. Eastern Time and concluding at about 2:00 p.m. Eastern Time.
Amyris is now one of the fastest growing small-cap companies on NASDAQ and, with Biossance, it has the fastest growing skincare brand in the U.S. Its products include specialty chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals, providing pure and sustainable alternatives to petroleum, plant and animal-based products, with a No Compromise™ approach to cost, performance and availability.
“Our successful business pivot over the past several years has been driven by our ongoing collaborations and development partnerships with leading global brands and distributors in Health, Beauty and Flavor and Fragrance ingredient markets,” said Amyris President & CEO John Melo. “This partnership business model helped fund our entry into becoming one of the fastest growing Clean Beauty brands in the US. We are committed to making natural, clean ingredients available to consumers, who want to reduce environmental impact in the brands they buy and use while using the best performing products at an accessible price.”
Melo and Joel Cherry, Amyris President of Research and Development, will host the event, which will be attended by investors and many of Amyris’s business partners. The day-long conference will include a keynote presentation by Juan Enriquez, Co-Author of “Evolving Ourselves,” Co-Founder of Synthetic Genomics, Inc., and Managing Director of Excel Venture Management. Enriquez will share his vision for how the Amyris technology performance and advantaged industrial fermentation capability is remaking chemistry and making our planet healthier. Thomas Kolditz, Founding Director of Doerr Institute for New Leaders, will speak at the pre-conference dinner on May 21.
Key themes to be explored at the event will include tapping into the science of Biotechnology to transform the beauty industry into better performing products that are healthy for us and sustainable for our planet.
Following the sessions on May 22, onsite attendees will then participate in an exclusive look into Amyris’s labs hosted by members of the company’s senior research & development team followed by a networking lunch.
A live videocast of the event will be available online on the Amyris website. To access the live videocast, please visit: http://investors.amyris.com. A replay of the videocast will be available on the Investor Relations section of the Company's website approximately two hours after the conclusion of the presentations and panel discussions. About Amyris
Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyrisapplies its innovative biotech solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise™ products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetic ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris, the Amyris logo, Biossance and No Compromise are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
Director, Investor Relations and Corporate Communications
+1 (510) 740-7481
Source: Amyris, Inc.